Capital Flow Monitor · Sponsors · CIK 1943061
SYNTIS BIO, INC.
135 MORRISSEY BLVD, BOSTON, MA, 02125 · 857-675-1109
Biotechnology · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$26.5M
Sold
$25.0M
% sold
94.3%
Investors
12
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-02 | D ·current | 506(b) | $26.5M | $25.0M | 94.3% | 12 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Rahul Dhanda — Executive Officer / Director, Boston, MA
- Robert Langer — Director, Boston, MA
- Carlo Giovanni Traverso — Director, Boston, MA
- Teymour Boutros-Ghali — Director, Boston, MA
- Martin Madaus — Director, Boston, MA
- Teymour Boutros-Ghali — Director, Boston, MA
- Chenny Zhang — Director, Boston, MA
- Michael Nannizzi — Director, Boston, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.